Abstract
An increased incidence of cardiovascular disease (CVD) has been shown after HCT, either autologous or allogeneic, compared with the normal population, with a cumulative incidence of cardiovascular events 15 years after HCT up to 6%. Screening of all patients who undergone an HCT is recommended in the international consensus guidelines. Knowing the risk factors and management of these complications and working with a multidisciplinary approach is essential to ensure the appropriate care of these patients.
Cite
CITATION STYLE
Galvan, E. R., Snowden, J. A., & Greenfield, D. M. (2024). Cardiovascular Diseases and Metabolic Syndrome. In The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies (pp. 495–500). Springer International Publishing. https://doi.org/10.1007/978-3-031-44080-9_55
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
